# Enveric Biosciences, Inc.: Form 8-K, filed Jun 1, 2015

- Company: [Enveric Biosciences, Inc.](/companies/envb.md) (CIK 890821)
- Form: 8-K
- Filed: 2015-06-01
- Accepted by EDGAR: Jun 1, 2015, 16:46 ET
- Period: 2015-05-26
- Accession: 0000921895-15-001521
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/890821/000092189515001521/form8k10211004b_05262015.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/890821/000092189515001521/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 3.02: Unregistered sale of equity
- Item 4.01: Change of auditor
- Item 5.01: Change in control
- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/890821/000092189515001521/form8k10211004b_05262015.htm

Filed Jun 1, 2015.
Source: SEC EDGAR, the filing index for accession 0000921895-15-001521. Last ingested by Listed: Nov 14, 2026, 20:02 ET. No prices; not investment advice.
